Stine Bosse MEP - Vital Signs

Sign in Subscribe

Stine Bosse MEP

A collection of 10 posts

Inside EU Health: EMA; competitiveness; response to MFN; West Nile Virus; EU/Mexico; Sanofi; EU4Health

Inside EU Health

Inside EU Health: EMA; competitiveness; response to MFN; West Nile Virus; EU/Mexico; Sanofi; EU4Health

EMA recommendations; De Wever urges EU integration to better compete; US most-favored nation; Record-high West Nile virus infections reported amid spread north; EU/Mexico; Sanofi; EU4Health 2026 budget approved

European Parliament to press Commission and Council over US drug pricing policies

Most Favored Nation

European Parliament to press Commission and Council over US drug pricing policies

The European Parliament’s Public Health (SANT) Committee adopted two oral questions on Thursday (15 October), calling on both the European Commission and the Council of the European Union to address the impact of US pharmaceutical pricing policies on access to medicines in Europe. Led by Danish Renew Europe MEP

MEPs pressed to close gaps in childhood cancer treatment

Childhood cancer

MEPs pressed to close gaps in childhood cancer treatment

The European Parliament's Public Health Committee focuses on childhood cancer and the need to give it greater attention

MEPs seek safeguards on new organ-processing technologies

Organ transplantation

MEPs seek safeguards on new organ-processing technologies

MEPs backed the potential of new organ-processing technologies to improve transplantation but called for safeguards to protect patient safety and non-commercial use

MEPs push for EU solidarity fund to improve access to cross-border healthcare

Cross-border healthcare

MEPs push for EU solidarity fund to improve access to cross-border healthcare

MEPs want to revive underused cross-border healthcare rights, with funding a key barrier

MEPs supportive of draft Biotech report, but divisions over incentives remain

MEPs supportive of draft Biotech report, but divisions over incentives remain

The European Parliament's first debate on its draft Biotech Act report showed broad political support for strengthening Europe's biotechnology sector, while exposing disagreements over how best to boost innovation, streamline clinical trials and incentivise investment. Presenting their joint report, co-rapporteurs Wouter Beke MEP (EPP, Belgium)

NGOs challenge UK-US medicines pricing deal

Most Favored Nation

NGOs challenge UK-US medicines pricing deal

NGOs accuse the British government of trading NHS pricing safeguards for export protection, as Washington intensifies efforts to push higher medicine costs across Europe

Inside EU Health: European Centre of Clinical Excellence for Pharmaceuticals; Insta battle over ‘My Voice, My Choice’; Health Policy Leader Index

Inside EU Health

Inside EU Health: European Centre of Clinical Excellence for Pharmaceuticals; Insta battle over ‘My Voice, My Choice’; Health Policy Leader Index

European Centre of Clinical Excellence for Pharmaceuticals; Instagram battle over ‘My Voice, My Choice’; Health Policy Index highlights ten MEPs; ECDC propose four new reference laboratories

Health Policy Index highlights ten MEPs and asks what does leadership mean in 2026

Health Policy Leaders Index

Health Policy Index highlights ten MEPs and asks what does leadership mean in 2026

Parliamentarians' set out their top priorities for 2026 amid growing uncertainty and geopolitical disruption

MEPs call for dedicated cancer funding in EU’s long-term budget

MEPs call for dedicated cancer funding in EU’s long-term budget

The European Cancer Organisation (ECO) has a clear message for the European Parliament: Europe’s Beating Cancer Plan is working and its future must now be secured. ECO warns that hard-won progress is at risk as negotiations begin on the EU’s next long-term budget for 2028–2034,